Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments

Breast cancer (BC) is the most common cancer occurring in women but also rarely develops in men. Recent advances in early diagnosis and development of targeted therapies have greatly improved the survival rate of BC patients. However, the basal-like BC subtype (BLBC), largely overlapping with the tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mieczkowska, Iga K., Pantelaiou-Prokaki, Garyfallia, Prokakis, Evangelos, Schmidt, Geske E., Müller-Kirschbaum, Lukas C., Werner, Marcel, Sen, Madhobi, Velychko, Taras, Jannasch, Katharina, Dullin, Christian, Napp, Joanna, Pantel, Klaus, Wikman, Harriet, Wiese, Maria, Kramm, Christof M., Alves, Frauke, Wegwitz, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630036/
https://www.ncbi.nlm.nih.gov/pubmed/34845197
http://dx.doi.org/10.1038/s41419-021-04407-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630036/
https://www.ncbi.nlm.nih.gov/pubmed/34845197
http://dx.doi.org/10.1038/s41419-021-04407-y

Ejemplares similares